|
FOLFOX regimen Clinical Trials
9 actively recruiting trials across 2 locations
Also known as: 0, Leucovorin, fluorouracil, and oxaliplatin, Oxaliplatin, Leucovorin, Fluorouracil, Oxaliplatin, folinic acid and 5-FU
Pipeline
Phase 1: 1Phase 2: 8
Top Sponsors
- UNICANCER4
- Weill Medical College of Cornell University1
- Providence Health & Services1
- Neil Kopek1
- GERCOR - Multidisciplinary Oncology Cooperative Group1
Indications
- Cancer9
- Liver Disease1
- Advanced Gastric Adenocarcinoma1
- Advanced Esophageal Adenocarcinoma1
- Locally Advanced Colorectal Carcinoma1
Other7 trials
New York, New York1 trial
Portland, Oregon1 trial
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
Providence Portland Cancer Institute - Franz Clinic
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.